Lubrizol’s Apinovex™ polymer was the proud recipient of a Celebration Award in the Pharma Excipients Award category at CPhI China, held in Shanghai, June 24-26. CPhI supports the global Pharma supply chain with multi-channel events and digital platforms in every region, where industry professionals can meet, learn and collaborate on APIs, CDMOs, excipients and more.

Apinovex polymer's win places it alongside another of Lubrizol's novel excipients, Apisolex™ polymer, with multiple awards, including CPhI’s 2023 Global Innovation Award and recognition as the Grand Winner of the 2023 Annual Medicine Maker Innovation Award. These awards underscore Lubrizol’s commitment to bringing the next generation of excipient technology to market, improving solubility and bioavailability of APIs to enhance drug delivery.

“We are excited to have received this additional recognition from CPhI following the earlier receipt of innovation awards for our novel injectable excipient, Apisolex™ polymer,” says Matt Finkelhor, Global Commercial Manager, Novel Polymers, Lubrizol. “The awards confirm that Lubrizol’s innovation is making a difference in drug delivery solutions that improve bioavailability to help bring more life-changing medications to market.”

The CPhI awards include nine award categories across the entire pharmaceutical industry, fully showcasing outstanding achievements in innovation, design, ingredients and excipients. The Pharma Excipients Award recognizes innovative products with high market potential, focusing on improving the technical standards of the pharmaceutical excipients industry, shaping outstanding examples in the global pharmaceutical excipients field, and leading to new trends in industry development.

Lubrizol’s Apinovex™ polymer wins CPhI China's 2025 Pharma Excipient Award